Every year, our scientists and patient advisory group identify the studies and topics creating the most impact for people living with arthritis.
Uncover Our Focus for 2026Ongoing and completed studies across our full research portfolio, from prevention and treatment to care and health systems.
Explore Our ResearchMeet the scientists, clinicians, trainees, and patient advisory board members, driving discoveries
Meet Our TeamArthritis Research Canada's scientists and trainees regularly present new findings that advance arthritis prevention, treatment, and care.
Browse Conference AbstractsPeople living with arthritis guide our research priorities, shape study design, and ensure our work reflects real life.
Support Arthritis Research Canada with your time and skills. Whether you want to help at an event or host your own, there is a place for you here.
Living with arthritis? Explore open studies looking for participants and help shape the future of arthritis care.
Your experience with arthritis matters. Sharing it helps others feel less alone and brings the human reality of arthritis into everything we do.
Reason For Research
Fatigue is prevalent among people with inflammatory arthritis and has detrimental impact on quality of life. There is a body of evidence suggesting that increased physical activity in inflammatory arthritis leads to overall health benefits such as improving joint health, mobility, and psychological well-being. Currently, the Effectiveness of Online Physical Activity Monitoring in Inflammatory Arthritis (OPAM-IA) trial is addressing the problem of inactivity in people living with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). The present study will use data from the OPAM-IA trial to assess the association between physical activity and fatigue level, and determine if the physical activity counselling program being tested in OPAM-IA can reduce the fatigue experienced by the participants. This study may support the future development of more effective treatment strategies for fatigue management in people living with inflammatory arthritis.
Execution of Research
Involvement
The OPAM-IA research team consists of 7 co-investigators, 6 research staff, and 12 collaborators. Approximately sixty people with RA and sixty people with SLE will be recruited. Eligibility criteria consists of:
Participants will be randomly assigned to one of the two groups to either receive the intervention immediately or wait 2 months before getting the intervention. Participants in the Immediate Group will be asked to attend a group education session, use a Fitbit Flex with the FitViz app, and receive counselling by a registered physiotherapist. Participants in the Delayed Group will wait 2 months to start the same intervention. Throughout the study, assessments will be done at the beginning, and at the end of months 2, 4, and 6. These assessments include an online questionnaire and wearing another research based accelerometer for 7 days.
Please note that recruitment for this study is now closed.
Greg Noonan, Mary Pack Arthritis Program Paul Adam, Mary Pack Arthritis Program Dr. Leigh Callahan, Thurston Arthritis Research Center Pam Montie, Arthritis Patient Advisory Board Cherly Koehn, Arthritis Consumer Experts Dr. John Esdaile, University of British Columbia, Arthritis Research Canada Dr. Kam Shojania, University of British Columbia, Arthritis Research Canada Dr. David Collins, University of British Columbia Dr. Jason Kur, Pacific Arthritis Centre Dr. Jennifer Reynolds, Vancouver General Hospital Dr. Ken Blocka, University of British Columbia Dr. Shahin Jamal, University of British Columbia